UMYU Journal of Microbiology Research

E-ISSN: 2814 – 1822; P-ISSN: 2616 – 0668

ORIGINAL RESEARCH ARTICLE

Prevalence of Multi Drug Resistant Coagulase Negative Staphylococci among some Pregnant Women Attending Antenatal Clinic in Yola, Nigeria

*Sale, M. and Kanu, S. N.

Department of Microbiology, MAU, Yola, Nigeria

Abstract

Coagulase negative staphylococci have been reported to be a frequent agent of uncomplicated UTI in young sexually active women which can also lead to symptomatic infection, low birth weight (LBW) babies and preterm delivery. This study was undertaken to determine the prevalence and characterize coagulase negative staphylococci among pregnant women in public health facilities in Yola. A total of 250 urine samples were collected from pregnant women attending antenatal clinic at Specialist Hospital and Boshang Clinic and Maternity both in Yola. The samples were cultured on cysteine lactose electrolyte deficient medium and isolates characterized using phenotypic methods. The prevalence of coagulase negative staphylococci from this study was 26.97%, Staphylococcus aureus 16.29% and Escherichia coli 36.51%. The frequency of CoNS was highest among age group of 36-40 years and least among 16-20 years (12.5%). CONS isolated from this study demonstrated high susceptibility to pefloxacin, ciprofloxacin, erythromycin, ceftriaxone and streptomycin. Some isolates showed high resistance to ampiclox, cefuroxime and amoxicillin. About 83% of the isolates had multiple antibiotic resistant indexes greater than 0.2 with about 25% of the antibiotic resistance being plasmid mediated. Furthermore, phenotypic screening using the double disk synergy test showed that 20 (40%) of the isolates were extended spectrum beta lactamase (ESBL) producing. This study revealed the presence of multi-drug resistant and ESBL producing coagulase negative staphylococci among pregnant women in the study area. There is therefore the need for pregnant women to be screened for coagulase negative staphylococci to avoid complications during gestation period.

Keywords: Coagulase negative, Staphylococcus, Pregnant women, Prevalence, Multidrug resistant

INTRODUCTION

Coagulase-negative staphylococci (CoNS) are gram-positive cocci with a characteristic “grape-like” shape and are distinguished from Staphylococcus aureus by their lack of coagulase production. They are part of the normal human flora but can sometimes cause infections, particularly in individuals with implanted devices, the elderly, young children, sexually active women, and immunocompromised patients (Deyno et al., 2018; Ali et al., 2019; Franҁa et al. 2021). While there are approximately 45 recognized species of CoNS, Staphylococcus epidermidis, Staphylococcus lugdenensis, Staphylococcus haemolyticus, and Staphylococcus saprophyticus are commonly associated with clinical diseases (Ali et al., 2019; Franҁa et al. 2021).

Reports have shown that Coagulase negative staphylococci is second only to E. coli as the most common causative organism in uncomplicated urinary tract infection (UTI) in young sexually active women. Ali et al (2019) have reported prevalence of CoNS to be 100% from Kano while 62.7% was reported in Ilorin by Kolawole (2012). Nicolle (2019) isolated S. saprophyticus from 173 (22 %) of 787 study subjects with bacteriuria . The study also showed that 42.3% of the infection occurring among women aged 25-31 years. E. coli, S. aureus and S. saprophyticus were the commonly encountered isolates from the study. Pregnant women aged 26-30 years had more infection than women aged 20-25 years, this they attributed to high sexual activity within that age bracket.

Coagulase negative staphylococci reportedly colonize the rectum and genitourinary tract in an age- and season-dependent manner (preferentially in rainy season). Dhukaa (2012) reported that 6.9% of the urogenital tract of healthy women is colonized (median age, 29 years) from an outpatient gynaecology clinic. In 40 % of humans however, the major reservoir of CoNS is the gastrointestinal tract. In sexually active women, Coagulase negative staphylococci are reportedly the common causes of urinary tract infection where they cause asymptomatic infection from the onset and progresses to form symptomatic disease known as cystitis. CoNS are reported to be the etiologic agent for more than 20% of UTI in pregnant women which can lead to symptomatic or chronic infection. Urinary tract infections caused by CoNS and other agents cause mild to severe health challenges on the mother, foetus and neonates with acute pyelonephritis, septicaemia, nephrolithiasis, endocarditis, neonatal sepsis, bacteremia, acute urinary tract infections, urethritis, dysuria, preterm delivery and low birth weight being the severe complications. Increased parity or age, lack of prenatal care, Low socioeconomic status, poor personal hygiene and sickle cell trait are some of the predisposing factors of UTI in pregnant women (Jain et al., 2013; Nicolle, 2019). Other factors that may lead to UTI may include functional urinary tract abnormalities and diabetes mellitus. Because of the concerns associated with coagulase negative staphylococci infections in pregnancy, we conducted this study to determine the prevalence of CoNS among pregnant women in Yola, Nigeria.

MATERIALS AND METHOD

ETHICAL APPROVAL

Approval to conduct this study was sought and obtained from the management of the various hospitals and clinics from where samples were collected. The reference number for the approval was MAU/MB/SHY/07/710/vol.1. Informed consent was obtained from all study subjects, and it served as the basis for their enrollment in the study.

Study Population

The subjects enrolled in this study were pregnant women that registered for ante natal clinic in public or private hospital in Yola irrespective of age, tribe and socioeconomic status that willingly volunteered to be included in the study

Sample Size

A total of 250 randomly collected urine samples from pregnant women showing no signs of urinary tract infection attending antenatal clinics in private and public hospitals in Yola, Nigeria, were randomly selected for this study while ensuring their confidentiality. An average prevalence of 80% reported by Ali et al (2019) and Kolawole (2012) was utilized to calculate the sample size using the formula N= Z^2 pq/d^2, where:

N= sample size

Z = Standard normal deviate at a 95% confidence interval.

P = Proportion of the target population

q= 1- p

d= degree of freedom.

Z = 1.962, p = 0.80, q = 1 - 0.80 = 0.20, and d = 0.052.

Thus;

N= 0.6159110/0.0025 =246.4

Therefore, a total sample of 246.4 was required, and this was rounded up to 250.

Sample Collection and Processing

The study subjects were instructed on how to collect the urine specimen following the methods reported by Chessbrough (2006). Briefly, early morning clean catch mid-stream urine samples were collected into sterile universal container containing boric acid. The urine sample was then labelled properly with information of age, occupation, parity, gestational age and be transported to the laboratory and processed using standard methods.

Urine Culture

The urine samples were inoculated on Cysteine Lactose electrolyte-Deficient (CLED) medium using a sterile wire loop. The inoculum was spread thinly over the plate area using the streaking method to allow for discrete colony growth. The plates were then incubated at 37 °C for 24 hours. The morphological characteristics of the bacterial growth were observed, and the colonies were counted to determine significant bacteriuria (Prescott et al., 2008).

Characterization of Bacterial Isolates

After the incubation period, isolates were identified using microscopic and biochemical tests. The biochemical tests conducted included catalase, coagulase, urease, oxidase, trehalose utilization tests, haemolytic test, novobiocin susceptibility, etc., as described by Chessbrough, (2006).

Antibiotic Susceptibility Test

Antibiotic susceptibility testing of pure cultures of confirmed isolates will be conducted on Mueller Hinton agar using the Kirby-Bauer disc diffusion method following the guidelines outlined in CLSI, (2017). To begin, a suspension of the fresh isolate will be prepared in sterile normal saline and standardized to a 0.5 McFarland standard. Subsequently, 0.2 ml of the bacterial suspension will be transferred onto molten Mueller-Hinton agar and evenly spread using a sterile glass spreader. Antibiotic discs obtained from Oxoid (Hampshire, United Kingdom) will then be placed on the agar using sterile forceps. The discs include Pefloxacin (5 µg), Gentamycin (30 µg), Ampiclox (20 µg), Cefuroxime (10 µg), Amoxicillin, Ceftriaxone (10 µg), Ciprofloxacin (5 µg), Streptomycin (10 µg), Cotrimoxazole (25 µg), and Erythromycin (15 µg). Following incubation at 37 ºC for 24 hours, the plates will be examined for the diameter of the zone of inhibition around each antibiotic disc. The zone diameters will be measured in millimeters and compared with a zone diameter interpretation chart provided by CLSI, (2017).

Screening of bacterial isolates for Extended Spectrum Beta Lactamase (ESBL) production

Coagulase-negative Staphylococcus isolates were screened for extended-spectrum beta-lactamase production following the guidelines outlined in CLSI, (2017). Individual antibiotic discs containing cefotaxime (30 µg) and ceftazidime (30 µg) were aseptically placed 30 mm apart on MH agar plates inoculated with the test organism and incubated for 18-24 hours at 37°C. After the incubation period, the zones of inhibition were measured and recorded to the nearest millimeter. ESBL production was suspected if any of the test bacteria exhibited a diameter of less than 27mm for cefotaxime and less than 22mm for ceftazidime susceptibility, or if they were resistant to any third-generation cephalosporins (cefotaxime and ceftazidime) (CLSI, 2017). Suspected ESBL-producing isolates were then confirmed for ESBL production using the double-disk synergy test as described by CLSI, (2017).

Biofilm Formation Test

The Congo red screening for biofilm formation was adopted. The medium was prepared with 37 g brain heart infusion broth, 50 g sucrose, 10 g agar, and 0.8 g Congo red per liter. Congo red stain was prepared as a concentrated aqueous solution, autoclaved at 121°C for 15 minutes, and then added to the other components of the culture medium when it cooled to 55°C. Plates were then inoculated with one or more colonies of the original isolate and incubated at 37°C for 24 hours. A positive result was indicated by the presence of black colonies on the surface, while strains that did not produce slime developed red colonies (Freeman et al., 1989).

Plasmid Curing Test

Coagulase Negative Staphylococcus spp were screened for the presence of plasmids using the 10% sodium dodecyl sulphate (SDS) method described by Mirmomeni et al., (2007). Isolates of Coagulase Negative Staphylococcus spp will be grown for 24 hrs and incubated at 37 °C in nutrient broth containing 10% SDS. After 24 hrs, the broth culture will be agitated to homogenize the content, and a loopful of the broth culture will then be subcultured onto Mueller Hinton Agar (MHA) plates, and antibiotic sensitivity testing will be carried out as previously described. Absence of a zone of inhibition on Mueller Hinton agar will indicate plasmid-mediated resistance (plasmid cured), while the presence of a zone of inhibition on Mueller Hinton agar indicates chromosome-mediated (plasmid not cured). Cured markers will be determined by comparison between the pre- and post-curing antibiogram of the isolates.

RESULTS

Results in Table 1 show that a total of 178 isolates were obtained from this study, with Staphylococcus saprophyticus being the only coagulase-negative staphylococci, accounting for 26.8% of the isolates. The other uropathogens isolated from the study include Escherichia coli 65(36.51%), Staphylococcus aureus 29(16.29%), Klebsiella pneumonia 19(10.67%), and Proteus mirabilis 17(9.55%).

The distribution of coagulase negative staphylococcus infection in relation to age of study subjects is shown in Table 2. The highest occurrence of coagulase negative staphylococcus infection is seen in the age group of 36-40 years followed by age group >45 yrs. 25%. and the lowest occurrence was seen in the age group 16-20 yrs. (12.5%).

Table 3 shows the distribution of coagulase negative staphylococcus in relation to gravidae. The highest occurrence of coagulase negative Staphylococcus infection was observed in the primigravidae while the multigravida had the least occurrence of coagulase negative staphylococci.

Coagulase-negative staphylococci were observed to be more prevalent among pregnant women in the third trimester (26.7%) but least common in the first trimester of pregnancy. The variation in the occurrence of coagulase-negative staphylococci was not statistically significant at p=0.05 (Table 4).

The results of the antimicrobial susceptibility screening of coagulase-negative staphylococci revealed that the majority of the isolates (over 70%) were susceptible to pefloxacin, ceftriaxone, ciprofloxacin, streptomycin, and erythromycin. Similarly, over 70% of the isolates demonstrated resistance to ampiclox, cefuroxime, and cotrimoxazole (Table 5).

Table 1: Percentage of occurrence and distribution of uropathogens among pregnant women

Isolates No of isolates Prevalence (%)
Escherichia coli 65 36.5
Staphylococcus saprophyticus 28 15.5
Staphylococcus epidermidis 12 6.6
Staphylococcus aureus 29 16.3
Klebsiella pneumonia 19 10.7
Proteus mirabilis 17 9.6
Total 178 71.2

Table 2 Distribution of coagulase negative staphylococcus in relation to age of the pregnant women

Age interval No. tested % positive P value
16-20 16 2 (12.5)

0.1824

P>0.05

21-25 60 10 (16.7)
26-30 107 20 (18.7)
31-35 48 8 (16.7)
36-40 15 7 (46.7)
>40-45 4 1 (25)
Total 250 48

Table 3: Prevalence of coagulase negative staphylococcus in relation to gravidity

Gravidity No. examined % positive P value
Primigravidae 29 22 (75.9) P< 0.05
Second Gravidae 53 15 (28.3)
Multiple Gravidae 168 11 (6.5)
Total 250 48

Table 4: Distribution of coagulase negative staphylococci in relation to trimester

Trimester Number positive Number examined P value
First trimester 26(17.3) 150 p>0.05
Second trimester 14 (2) 70
Third trimester 8 (26.7) 30
Total 48 250

Table 5: Antibiotics susceptibility profile of Coagulase negative Staphylococcus isolates

Antibiotics Susceptible Intermediate Resistant
Pefloxacin 42(87.5) 1(2.1) 5(10.4)
Gentamycin 29(60.4) 8(16.7) 11(22.9)
Ampiclox 7(14.6) 1(2.1) 40(83.3)
Cefuroxime 5(10.4) 5(10.4) 38(79.2)
Amoxicillin 10(20.8) 5(10.4) 33(68.8)
Ceftriaxone 34(70.8) 1(2.1) 13(27.1)
Ciprofloxacin 41(85.4) - 7(14.6)
Streptomycin 34(70.8) 2(4.2) 12(25)
Cotrimoxazole 8(16.7) 3(6.3) 37(77.1)
Erythromycin 34(70.8) 5(10.4) 9(18.6)

Figure 1 Multiple antibiotics resistance of coagulase negative staphylococci from pregnant women.

Key: MAR- multiple antibiotics resistance

Table 6: ESBL production among bacterial isolates using Double Synergy method

  Presumptive Confirmed Negative
S. saprophyticus 14 6 8
S. epidermidis 6 2 4
Total 20 8 12

Key: Presumptive (Cefpodoxime =≤22mm, Ceftriaxone=≤25mm, and Ceftazidime =≤ 22mm, confirmed using the double disc synergy test by observing the expansion of the indicator cephalosporin inhibition zone towards antibiotics with Clavulanic acid.

DISCUSSION

The prevalence of urinary tract infection due to coagulase-negative staphylococci among pregnant women in this study was 26.8%, second only to Escherichia coli with a prevalence of 35.5%. This rate is slightly higher than the 21.6% reported by Matalka et al. (2021) but lower than the 42.3% reported by Nicolle, (2019) among women aged 25-31 years. The prevalence of coagulase-negative staphylococci from this study confirms earlier reports of CoNS being the second most common agent of uncomplicated UTI in sexually active women, following E. coli. The physiological changes in a woman’s body during pregnancy increase the risk of urinary stasis and vesicoureteral reflux. These changes, coupled with challenges in maintaining proper hygiene due to a distended pregnant belly and a naturally short urethra, contribute to the higher frequency of urinary tract infections during pregnancy.

From the results of this research, the overall prevalence of bacterial isolates was 71.2%. Comparing this result with other studies on the prevalence of pathogens associated with UTI, previous research by Obiogbolu et al., (2009) in Akwa metropolis, South-eastern Nigeria, highlighted E. coli as a common urinary tract pathogen, with a reported high incidence of UTIs (54%) in pregnant women. Similarly, Okesola and Oni, (2005) found that the most prevalent uropathogens in urine were Staphylococcus aureus (47.5%), Pseudomonas aeruginosa (24.6%), Klebsiella species (23%), Proteus spp (3.3%), and E. coli (1.6%). These findings suggest that there has been limited focus on coagulase-negative staphylococci, which studies have shown account for more than 20% of UTIs in pregnant women (Nicolle, 2019).

The highest occurrence of coagulase-negative staphylococcus infection is observed in pregnant women aged 36-40 years (25%). However, this difference is not statistically significant at p=0.05. This could be attributed to the high level of sexual activity within this age group, as sexual activity increases the risk of UTI, and women in this age bracket are typically sexually active. This finding contrasts with the report by Akinloye et al (2006) who identified advanced maternal age (≥ 35 years) as a risk factor for asymptomatic bacteriuria in pregnancy.

The highest occurrence of coagulase-negative Staphylococcus infection observed in primigravidae can be attributed to the pressure effect of a larger uterus on the ureter and pressure on the bladder from the descending part, leading to stasis of urine and increased multiplication of bacteria. Akinloye et al (2006) also reported that multiparity is a risk factor for acquiring asymptomatic bacteriuria in pregnancy. There was a significant difference in the prevalence of asymptomatic bacteriuria with respect to gravidity (P=0.000).

Coagulase-negative staphylococci infection was observed to be more common among pregnant women in the third trimester. This is due to the high level of progesterone produced during pregnancy, which relaxes the urinary tract, thereby causing urine to remain longer in the system, resulting in the growth and accumulation of pathogens. This condition, along with the weight of the growing uterus on the bladder, leads to urinary stasis, thereby increasing the risk of infection during pregnancy. In this study, the peak of infection occurs in the second trimester (54.17%), which agrees with the work of John et al, (2018), that shows a higher frequency of CoNS in the second trimester and closely in the third trimester. This study differs from that of Fred et al. (2015), who reported a higher frequency of CoNS in the third trimester than in the first and second trimester. Okonko et al. (2010) also reported a higher prevalence in the third trimester in a study to detect CoNS among pregnant women in Ibadan, South-Western Nigeria. This difference may be attributed to changes in urinary stasis and vesico-urethral reflux, personal hygiene, or a decrease in urinary hormones in the various trimesters of pregnancy.

Results of the antimicrobial susceptibility screening of coagulase-negative staphylococcus revealed that the majority of the isolates (over 70%) were susceptible to pefloxacin, ceftriaxone, ciprofloxacin, streptomycin, and erythromycin. Similarly, over 70% of the isolates demonstrated resistance to ampiclox, cefuroxime, and cotrimoxazole. The antibiotic susceptibility pattern results show that CoNS were highly susceptible to pefloxacin (87.5%), ciprofloxacin (85.42%), erythromycin, ceftriaxone, and streptomycin (70.83%). This finding is consistent with a previous study by Akinloye et al (2006) where Staphylococcus saprophyticus showed resistance (100%) to amoxicillin, ampiclox, and ceftazidime, with 66.7% resistance to erythromycin and cotrimoxazole. CoNS have been reported to be resistant to a wide spectrum of antibiotics, with many species commonly resistant to antibiotics currently used for staphylococcal infections. The use of antibiotics in hospitals has created a reservoir of antibiotic resistance genes and has contributed to the accumulation of resistant coagulase-negative staphylococci strains.

About 80% of CoNS isolates from this study had multiple antibiotic resistance (MAR) indexes above 0.2. This indicates that a significant proportion of the bacterial isolates have been exposed to multiple antibiotics and have consequently developed resistance to these drugs. Moreover, a MAR index exceeding 0.2 suggests that these bacterial strains likely stem from an environment where antibiotics are frequently misused, abused, or of substandard quality.

Presence of 16.7% ESBL-producing isolates among the pregnant women implies the risk of treatment failure even when using third-generation cephalosporin. This will increase the vulnerability of the pregnant women to all risks associated with such organisms on the pregnant women, fetus, and neonates. The presence of plasmids in some of the isolates could also imply possible horizontal transfers to other isolates, thereby further increasing the risk. A few isolates showed resistance after curing, indicating that such resistance was chromosomally borne.

Biofilm formation was observed among the isolates, which is consistent with the known ability of cons to produce slime and adhere to surfaces, particularly indwelling devices. This characteristic makes the clearance of these organisms from the system challenging due to the resistance of the microbial communities to antimicrobial substances.

CONCLUSION

This study has shown a CoNS prevalence of 26.8% in urine samples collected from pregnant women in the study area. The research also confirmed the presence of multidrug-resistant CoNS isolates, with some of the resistance likely being plasmid-mediated. Therefore, it is recommended that pregnant women be screened for CoNS and their antibacterial profiles during their antenatal clinics. Additionally, pregnant women should adhere to good personal hygiene practices to reduce the risk of Staphylococcus infection.

REFERENCES

Akinloye O., Ogbolu D. V., Akinloye O. M., Terry-Alli, O. A. (2006) Asymptomatic bacteriuria of  pregnancy in Ibadan, Nigeria a reassessment. British Journal of Biomedical Sciences  63(3)109- 112. [Crossref]

Ali, M., Ibrahim, S. M., Nas, F. S. and Garba, K. A. (2019) Prevalence of Staphylococcus  Species  from Clinical Samples Obtained from Some Hospitals on Kano Metropolis, Nigeria.  American  Journal of Biomedical Sciences and Research. 5(3). 207-211 AJBSR.MS.ID.000913. [Crossref]

Chessbrough, M. (2006) District laboratory practice in tropical Countries 2nd edn(2) Cambridge University Press UK 182-187

Clinical Laboratory Standard Institute (2017). Performance standards for anti-microbial disk susceptibility tests; Approved standard-9th Ed. CLSI.

Deyno, S., Fekadu S, and Seyfe, S. (2018)) Prevalence and antimicrobial resistance of coagulase  negative  staphylococci clinical isolates from Ethiopia: a meta-analysis BMC Microbiology 18:43  [Crossref]

Dhukaa, A. A. (2012) Urinary tract Infection among pregnant women in Mosul city. Annals of the  college of medicine 38(2): 35-39. [Crossref]

Franҁa , A. Gaio, V., Lopes N and Melo I. D. R (2021) Virulence factors in coagulase negative  staphylococci pathogens 10:2, 170 [Crossref]

Fred, N. W., Gichuchi J. W. Mugo N. W. (2015) Prevalence of urinary tract infection, aetiology and  antibiotic sensitivity pattern among antenatal women presenting with lower abdominal pain  in Kenyatta National hospital, Nairobi, Kenya.

Freeman J. Falkiruf, F. R. Keane, C. T. (1989) New Method for detecting slime production by  coagulase  negative staphylococci. Journal of Clinical Pathology 42: 872-874. [Crossref]

Kolawole, O. M., Agbede,O. O., Ogunleye, V. F. and Adegoke, A. A. ( 2012) Incidence of  novobiocin  resistant coagulase negative Staphylococcus saprophyticus in urinary tract  infection in UITH, Ilorin,  Nigeria. E3 Journal of Medical Research 1(4). .044-051

Mirmomeni, M. H., Colagar, A. H. and Ghazaey, S. (2007). Molecular study of Salmonella enteritidis  in poultry samples by pcr, plasmid curing, antibiotic resistance and protein  pattern analysis.  Pakistani Journal of Biological Sciences 10: 1562-1570. [Crossref]

Mohammed M (2015) Urinary tract infection among pregnant women attending a medical centre in Kaduna Nigeria. African Journal of Clinical and experimental Microbiology 16 (1)7-11. [Crossref]

Nicolle L. E., Gupta, K, and Bradley SF, (2019) Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clinical Infectious Disease.; 68:1611–1615. [PubMed: 31506700]. [Crossref]

Obiogbolu, C.H., Okonko, I.O., Anyamere, C. O. Adedeji, A. O. Akanbi , A. O., Ogun, A. A.  Ejembi T.  and Faleye, T. O. C. Incidence of Urinary Tract Infections (UTIs) among  pregnant women in Akwa  metropolis, South Eastern Nigeria Scientific Research and Essay.  4 (8): 820-824

Okesola, A. O. and Oni, A. A. (2009). Antimicrobial resistance among common bacterial  pathogens in  Southwestern Nigeria. America-Euroasia Journal of Environmental Sciences  5(3) 323-330

Okonko, I. O., Ijandipe, L. A., Ilusanya, A. O., Donbraye-Emmanuel, O. B., Ejembi, J., Udeze A.  O.,  Egun O. C., Fowotade A. and Nkang A. O. (2010) Detection of Urinary Tract Infection  (UTI)  among pregnant women in Oluyoro Catholic Hospital, Ibadan, South-Western Nigeria  Malaysian  Journal of Microbiology 6(1): 16-24. [Crossref]

Prescott, M., Harley, P. and Klein, A. (2008). Microbiology 7th edition. McGraw-Hill: New York. pp.  124-126.